HFA Premium Access

The risk of bias of current novel circulating biomarker studies for the detection of HFpEF and left ventricular diastolic dysfunction

Congress Presentation

About the speaker

Mr Michiel Henkens

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))
0 follower

10 more presentations in this session

Role of neprilysin in myocardial tissue Renin-Angiotensin-System (RAS) of the failing heart

Speaker: Doctor N. Pavo (Vienna, AT)

Thumbnail

The value of tubular maximum phosphate reabsorption capacity, a functional proximal tubular parameter in heart failure

Speaker: Ms L. Emmens (Groningen, NL)

Thumbnail

The effect of liraglutide on natriuretic peptides and copeptin in heart failure patients

Speaker: Doctor R. Nielsen (Aarhus, DK)

Thumbnail

Improvement of existing strategies to prevent heart failure after myocardial infarction: a potential role for thrombopoietin

Speaker: Associate Professor L. Malinova (Saratov, RU)

Thumbnail

Plasma Tenascin-C: a novel prognostic biomarker in heart failure with preserved ejection fraction

Speaker: Doctor P. Kanagala (Liverpool, GB)

Thumbnail

Access the full session

Rapid Fire 2 - Biomarker: present and future

Speakers: Mr M. Henkens, Doctor N. Pavo, Ms L. Emmens, Doctor R. Nielsen, Associate Professor L. Malinova...
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb